Keyphrases
Advanced Breast Cancer
100%
Breast Cancer
28%
Circulating Tumor DNA (ctDNA)
42%
Clinical Manifestations
14%
Colombia
100%
Colombians
14%
Conventional Treatment
28%
Cost-effectiveness
100%
Current Costs
14%
Decision Tree Modeling
14%
Deterministic Analysis
14%
Docetaxel
14%
Drug Costs
14%
Economic Evaluation
14%
Financial Capacity
14%
HER2-positive
100%
HER2-positive Advanced Breast Cancer
28%
HER2-targeted Therapy
28%
High Health Care Cost
14%
High Sensitivity
14%
High Specificity
14%
Incremental Cost
14%
Liquid Biopsy
100%
Literature Search
14%
Local Studies
14%
Minimally Invasive
14%
Modeling Analysis
14%
Molecular Resistance Mechanism
14%
Molecular Treatment
14%
Pertuzumab
14%
Pharmacological Treatment
14%
Poor Prognosis
14%
Price Information
14%
Quality-adjusted Life Years
42%
T-DM1
14%
Trastuzumab
14%
Treatment Change
100%
Treatment Costs
14%
Treatment Line
14%
Treatment Resistance
14%
Window of Opportunity
14%
Medicine and Dentistry
Breast Cancer
100%
Cost-Effectiveness Analysis
100%
Docetaxel
14%
Drug Therapy
14%
Health Care Cost
85%
Liquid Biopsy
100%
Pertuzumab
14%
Quality Adjusted Life Year
42%
Sensitivity and Specificity
28%
Trastuzumab
14%
Nursing and Health Professions
Breast Cancer
100%
Cost Effectiveness Analysis
100%
Decision Tree
14%
Docetaxel
14%
Drug Therapy
14%
Economic Evaluation
14%
Health Care Cost
14%
Information Systems
14%
Liquid Biopsy
100%
Pertuzumab
14%
Quality Adjusted Life Year
42%
Sensitivity and Specificity
28%
Trastuzumab
14%
Agricultural and Biological Sciences
Docetaxel
33%
HER2-Positive
100%
Information Systems
33%
Pertuzumab
33%
Trastuzumab
33%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Docetaxel
20%
Pertuzumab
20%
Trastuzumab
20%